These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 303196)

  • 21. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of immunosuppressive and anti-inflammatory drugs on lymphocyte population and MIF in glomerulonephritis.
    Janas-Boratyńska M; Szewczyk Z
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):833-45. PubMed ID: 398689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological indicators in newly detected pulmonary tuberculosis with different degree of infiltration].
    Khomenko AG; Averbakh MM; Gergert VIa; Chukanov VI; Protopopova NM
    Probl Tuberk; 1981 Feb; (2):19-24. PubMed ID: 6972526
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated hypersensitvity in glomerulonephritis.
    Janas-Boratyńska M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):15-27. PubMed ID: 312632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Various mechanisms of the injurious effect of beryllium on the body].
    Vasil'eva EV; Ivanova LA; Sokolov VV
    Gig Tr Prof Zabol; 1979 Feb; (2):15-9. PubMed ID: 312752
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of active E rosette forming T lymphocytes by hyaluronic acid. Evidence of a receptor for hyaluronic acid on a lymphocyte subpopulation.
    Chevrier A; Girard N; Delpech B; Gilbert D
    Biomed Pharmacother; 1982 Mar; 36(2):100-3. PubMed ID: 6982077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the protective action of diphosphonic compounds against a T-lymphocyte lesion by antilymphocyte serum].
    Zernov IN; Stefani DV; Vel'tishchev IuE
    Biull Eksp Biol Med; 1979 Mar; 87(3):259-60. PubMed ID: 311661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of feline T and B cells.
    Kuramochi T; Takeishi M; Ishida T; Kato K; Ishida M
    Am J Vet Res; 1987 Feb; 48(2):183-5. PubMed ID: 3493718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migration inhibition of T lymphocytes from human peripheral blood by specific antigen and lymphokines.
    Kowalczyk D; Zembala M
    Clin Exp Immunol; 1978 May; 32(2):333-8. PubMed ID: 307468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hypersensitivity to beryllium compounds.
    Marx JJ; Burrell R
    J Immunol; 1973 Aug; 111(2):590-8. PubMed ID: 4717994
    [No Abstract]   [Full Text] [Related]  

  • 33. [Specific humoral and cellular reactions in beryllosis].
    Vasil'eva EV; Ermakova NG; Orlova AA
    Gig Tr Prof Zabol; 1977 Jul; (7):8-12. PubMed ID: 892561
    [No Abstract]   [Full Text] [Related]  

  • 34. [State of cellular immunity in diabetes mellitus (a review of the literature)].
    Martynova MI; Smirnov VV; Mazurina NA
    Vopr Okhr Materin Det; 1978 May; 23(5):49-53. PubMed ID: 351950
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nature of the blocking action of the sera of oncological patients on T-lymphocytes].
    Grigor'eva MP; Kosmiadi GA; Shelepina TA
    Vopr Onkol; 1979; 25(5):29-32. PubMed ID: 313622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic informative value of immunological tests in the acute period of myocardial infarct with an atypical onset and course].
    Selivanov II; Chukaeva II; Korochkin IM; Arion VIa
    Ter Arkh; 1980; 52(12):15-8. PubMed ID: 7017997
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of T-lymphocyte mediators in the pathogenesis of psoriasis].
    Kozin VM; Adamenko GP; Bogdanovich LI; Stel'machenok GE
    Vestn Dermatol Venerol; 1987; (7):36-9. PubMed ID: 3499715
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
    Staite ND; Messner RP; Zoschke DC
    J Immunol; 1987 Oct; 139(7):2424-30. PubMed ID: 2958549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.